Archive for the ‘stable’ tag
New Geodon HCP campaign
Brand name: Geodon
Generic name/category: Ziprasidone, Atypical antipsychotic
Company: Pfizer
Country/Market: USA, North America
Indication(s)/use: acute agitation in schizophrenic patients and acute treatment of mania and mixed states associated with bipolar disorder
Target: Healthcare Professionals (HCP)
Tagline: See me for who I can be
Medium: Print ad
Size/duration: single-page
Publication/Aired: October and November 2009
To see all of this brand’s ads on AdPharm, click here
AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.
Eloxatin – Sailboat
Deux contextes… Pensez à Eloxatin
Métastatique/Adjuvant
Schéma FOLFOX4 a démontré
Dans le traitement adjuvant du cancer du côlon de stade III (vs le schéma 5-FU/LV):
Amélioration de la survie sans maladie.
Amélioration quantitative de la survie globale.
Dans le traitement du cancer colorectal métastatique chez les patients n’ayant reçu aucun traitement préalable (vs le schéma IFL):
Amélioration de l’intervalle médian dans progression de la maladie.
Prolongation de la survie globale médiane.
Two contexts … Think of Eloxatin
metastatic/adjuvant
Figure FOLFOX4 demonstrated
In the adjuvant treatment of colon cancer stage III (vs 5-FU/LV):
Improved disease-free survival.
Quantitative improvement in overall survival.
In the treatment of metastatic colorectal cancer patients who received no prior treatment (vs. IFL diagram):
Improved median interval in disease progression.
Extension of the median overall survival.
Oxaliplatin is a platinum-based cancer chemotherapy drug. These drugs are usually classified as alkylating agents, although they are not capable of actually adding alkyl groups to DNA and simply work by a similar mechanism.
Oxaliplatin is typically administered with fluorouracil and leucovorin in a combination known as FOLFOX for the treatment of colorectal cancer. Oxaliplatin is marketed by Sanofi-Aventis under the trademark Eloxatin or by Medac GmbH under the trademark Oxaliplatin Medac. There are generic equivalents on the market now
Brand name: Eloxatin
Generic name/category: Oxaliplatin, Oncology, chemotherapy
Company: Sanofi Aventis
Country/Market: Canada, North America
Indication(s)/use: colorectal cancer
Target: Healthcare Professionals (HCP)
Tagline: Un choix éprouvé – A reliable choice
Medium: Print ad
Size/duration: single-page
Publication/Aired: Le Patient – July 2009
To see all of this brand’s ads on AdPharm, click here
Visit AdPharm.net for more pharmaceutical ads
